ACADVL rs1057517386: What Your Genotype Means
The rs1057517386 variant is a genetic marker located within the ACADVL gene, which is responsible for producing an enzyme essential for fatty acid metabolism. This specific variant is frequently documented in clinical datasets, though its individual impact on health remains a subject of ongoing scientific study.
What each genotype means
Common genetic variant
This genotype represents the most frequently observed sequence at this position in the ACADVL gene. Current clinical databases do not associate this specific genetic sequence with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency or other known clinical conditions.
This is the most common genotype observed in general population datasets.
Common genetic variant
This genotype represents a common variation at this position in the ACADVL gene. There is no evidence in current clinical literature to suggest that carrying one copy of this variant impacts the function of the VLCAD enzyme or increases the risk for related metabolic disorders.
This genotype is observed at a frequency consistent with common variation in the general population.
Common genetic variant
This genotype is frequently documented in clinical databases as a common variation within the ACADVL gene. It is not considered to be a pathogenic mutation, and there is no evidence linking this specific genotype to VLCAD deficiency or impaired fatty acid metabolism.
This genotype is commonly found across diverse ancestral populations.
Understanding the Variant and Its Location
The variant rs1057517386 is a single nucleotide polymorphism (SNP) situated on chromosome 17 at position 7,224,479 (GRCh38). In the context of human genomics, SNPs are the most common type of genetic variation, representing a difference in a single DNA building block, or nucleotide. This particular variant is located within the ACADVL gene, a region of the genome that has been extensively mapped and studied due to its critical role in cellular energy production. Because it sits within a gene that is vital for metabolic processes, researchers monitor such variants to determine if they influence how the body processes fats. While many variants in this region are benign, the location of rs1057517386 makes it a point of interest for geneticists who study how subtle changes in our DNA sequence might contribute to broader biological diversity or specific metabolic traits.
The Role of the ACADVL Gene
The ACADVL gene provides instructions for making an enzyme called very long-chain acyl-CoA dehydrogenase (VLCAD). This enzyme is located in the mitochondria, the powerhouses of our cells, and is essential for the process of fatty acid beta-oxidation. Essentially, VLCAD acts as a catalyst for the first step in breaking down very long-chain fatty acids into energy that the body can use, especially during periods of fasting or intense physical exertion. When the ACADVL gene functions normally, the body efficiently converts these fats into fuel. However, mutations in this gene can lead to a condition known as VLCAD deficiency, which impairs the body's ability to produce energy from these specific fats. Understanding the function of this gene is crucial because it highlights why researchers pay close attention to any variants found within its sequence, as even minor alterations could theoretically impact the efficiency of this vital metabolic pathway.
Research Associations and Evidence Strength
The evidence regarding rs1057517386 is primarily derived from its presence in clinical and genomic databases. While it is noted in catalogs like SNPedia and tracked by clinical expert panels, it is important to distinguish between a variant being 'noted' and a variant being 'causative.' Many variants identified in clinical settings are classified as variants of uncertain significance (VUS), meaning there is not yet enough evidence to definitively label them as harmful or benign. Current research into ACADVL often focuses on identifying which specific mutations lead to clinical deficiency versus those that are simply part of normal human genetic variation. For rs1057517386, the evidence strength is considered moderate in the context of clinical reporting. It is frequently observed in large-scale datasets, but it does not currently carry a definitive clinical classification as a primary driver of disease in the general population.
Population Frequency and Interpretation
The rs1057517386 variant is documented as being common in clinical datasets. In genomics, 'common' typically refers to the frequency at which a specific allele appears across different populations. Because this variant is frequently seen in clinical testing, it is well-represented in the databases that clinicians use to compare patient results. However, frequency alone does not determine the health impact of a variant. It is common for many genetic variations to exist at relatively high frequencies without causing any observable health issues. When interpreting this information, it is essential to remember that genetic data is complex and context-dependent. The presence of a common variant is often just one piece of a much larger biological puzzle, and it should not be viewed in isolation when considering overall health or metabolic function.
What You Can Do With This Information
If you have received information about your status for rs1057517386, it is important to approach it with a clear understanding of its limitations. This variant is a marker, not a diagnostic tool. It cannot predict your health outcomes or diagnose a metabolic condition on its own. If you are concerned about your metabolic health, energy levels, or family history of fatty acid oxidation disorders, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help interpret your genetic results in the context of your personal medical history, physical symptoms, and other clinical tests. Avoid making any changes to your diet, exercise, or medical regimen based solely on a single genetic variant. Always discuss any findings from genetic reports with a qualified clinician who can provide personalized guidance based on established medical standards.
How common is this variant?
The rs1057517386 variant is noted as being common in clinical datasets, appearing frequently across various populations in genomic research.
Frequently asked questions
Is rs1057517386 a sign of a genetic disease?
No, the presence of this variant alone is not a diagnosis of a genetic disease. It is a common genetic marker, and most variants in the ACADVL gene do not cause clinical symptoms.
Should I be worried if I have this variant?
There is no reason for concern based on this variant alone. It is a normal part of human genetic variation, and you should discuss any health concerns with your doctor.
Can I use this information to change my diet?
You should not change your diet based on this genetic information. Always consult with a registered dietitian or your physician before making significant changes to your nutritional intake.
Where can I find more information about ACADVL?
You can find reliable information about the ACADVL gene through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057517386?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACADVL
This SNP is located in the ACADVL gene region and is noted as a common variant in clinical databases.
This variant is associated with carrier status for Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency, an autosomal recessive metabolic disorder.
This variant is associated with carrier status for Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency.
This variant is associated with carrier status for VLCAD deficiency.